ratio of readmission was 2.12 (95% Confidence Interval: 1.47-3.10, P<0.001) with each 10-meter decrease of 6MWD. The ROC curve showed that the cut-off value of 6MWD was 425 meters (Figure) . Conclusion: The 6MWD measured at the discharge was identified as an independent predictor for readmission due to worsening CHF in middle-aged CHF patients and its cut-off value was 425 meters.
P3371 | BEDSIDE Prevention of seating-induced postural hypotension and its symptoms by leg compression bandaging during mobilization of inpatients
Purpose: Seating-induced Postural Hypotension (PH) has been reported in older inpatients. However, little is known about its prevention. We aimed to evaluate the eventual effects of leg compression bandages on seating-induced PH in the context of various relevant clinical variables. Methods: Included were 73 hospitalized patients with various acute conditions, aged 60 years and more, bedridden for at least 8 hours, with diagnosed PH (≥20 mm Hg systolic and/or ≥10 mm Hg diastolic blood pressure falls) at the first seating. Blood pressure, heart rhythm, dizziness and palpitations were recorded before and during 5 minutes of sitting. On the next day, the patients were reevaluated, this time using moderate compression bandages applied along both legs before seating. Depending on the persistence of PH at the 2nd day of the study, the patients were divided into two groups: with and without persisting PH. Results: Compared to non-bandaged state, PH was registered only in 53% of bandaged patients (P<0.001). Moreover, appearance of PH symptoms was decreased (43.8% vs. 34.2%, respectively, P<0.001). Demographic characteristics, main reasons for admission, duration of bed rest, prevalence of comorbidities and treatment with relevant medications were comparable between patients with or without persisting PH. However, on the 2nd day mean values of supine diastolic blood pressure were significantly higher in the group with persisting PH (82.1±17.7 vs. 73.6±14.3 mm Hg, P=0.027). In patients with PH disappearing following bandaging, the PH symptoms were significantly reduced at the 2nd day (P=0.003). Even in patients with persistent PH, the magnitude of blood pressure decline and appearance of PH symptoms were decreased while wearing bandages (P=0.004 and 0.002, respectively). Conclusions: During mobilization of inpatients, leg compression bandages seem beneficial for reducing the seating-induced PH and relevant symptoms. Even in patients with persisting PH, bandaging would be advantageous for improving hemodynamics and attenuating the associated symptoms. Purpose: Ivabradine (Iva) is recommended for patients with stable Coronary Artery Disease (CAD) who do not tolerate β-adrenergic blockade. As Iva does not affect cardiac contractility, central hemodynamics or lung function, we speculated, that switching therapy from β-blockers to Iva may improve cardiopulmonary overall performance. Methods: 19 patients (3 women, age 61±10 years, LVEF 61±5%) with arterial hypertension and CAD were included. In all patients chronic β-blocker therapy was going to be replaced by Iva due to side-effects of β-blockade. We performed cardiopulmonary exercise testing, pulmonary function testing and echocardiography and determined NT-proBNP serum levels both under β-blockade and after 6 weeks of Iva therapy (average daily dosage 13.6±2.5 mg). Results: Mean HR (by holter monitoring: 68±8 vs. 67±10 bpm; n=14; p=0.508), systolic blood pressure (128±13 vs. 133±16 mmHg; p=0.224), pulmonary vital capacity (p=0.726) and relative forced expiratory volume in 1 second (p=0.969) were not different under β-blocker or Iva at resting conditions. Echocardiographic left ventricular filling index (E/e') was slightly lower under Iva (11.4±4.8 vs. 9.2±3.2; n=16; p=0.085). None of the patients showed signs of myocardial ischemia at rest or under exercise. Patients achieved the same level of exercise duration (620±222 vs. 605±192 sec; p=0.620), maximal power (123±36 vs. 122±34 W; p=0.846), serum lactate levels (4.25±0.38 vs. 4.05±0.40 mM/L; n=15; p=0.529) and heart rate increase (52±19 vs. 52±13 bpm; p=0.967) with or without β-blockade. Although peak oxygen uptake (21.9±5.4 vs. 22.3±4.4 ml/min/kg; p=0.470) did not change, oxygen uptake at the anaerobic threshold significantly increased from 9.8±1.5 to 11.5±1.8 ml/min/kg (p=0.008) and peak oxygen pulse revealed an increase from 193±41 to 210±37 μl/beat/kg (p=0.010) after switching therapy to Iva. Interestingly, NT-proBNP serum levels were not different under β-blockade or Iva at rest (177±179 vs. 162±169 pg/ml; p=0.472), but the increase of serum levels during exercise tended to be lower under Iva (17±45 vs. 7±18 pg/ml; n=16; p=0.070). Conclusions: Switching therapy from β-blockers to Iva in patients with coronary artery disease leads to a significant delay in the onset of anaerobic metabolism as demonstrated by higher oxygen uptake at the anaerobic threshold during exercise. Moreover, left ventricular fillings pressures and NT-proBNP serum levels tended to be lower under Iva therapy. The results of this pilot study suggest, that compared to β-blockade, therapy with Iva could make patients more resistant to fatigue in everyday life and activity.
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